iBio
IBIO
#10327
Rank
NZ$90.21 M
Marketcap
NZ$1.40
Share price
6.59%
Change (1 day)
-38.81%
Change (1 year)

Earnings for iBio (IBIO)

Earnings in 2026 (TTM): -NZ$57.42 Million

According to iBio's latest financial reports the company's current earnings are NZ$0.1 Million. In 2025 the company made an earning of -NZ$43.79 Million a decrease over its 2024 earnings that were of -NZ$24.97 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for iBio from 2008 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$57.42 Million31.14%
2025 -NZ$43.79 Million75.34%
2024 -NZ$24.97 Million-32.2%
2023 -NZ$36.83 Million-50.39%
2022 -NZ$74.24 Million122.23%
2021 -NZ$33.41 Million-12.52%
2020 -NZ$38.19 Million45%
2019 -NZ$26.34 Million-3.71%
2018 -NZ$27.35 Million5.52%
2017 -NZ$25.92 Million18.82%
2016 -NZ$21.82 Million60.34%
2015 -NZ$13.61 Million38.31%
2014 -NZ$9.84 Million25.01%
2013 -NZ$7.87 Million
2010 -NZ$21.82 Million360.89%
2009 -NZ$4.74 Million5.77%
2008 -NZ$4.48 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$33.37 B-56,845.78%๐Ÿ‡บ๐Ÿ‡ธ USA
Genocea Biosciences
GNCA
-NZ$66.3 Million 12.73%๐Ÿ‡บ๐Ÿ‡ธ USA
Nektar Therapeutics
NKTR
-NZ$0.28 Billion 364.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
-NZ$0.17 Billion 188.26%๐Ÿ‡บ๐Ÿ‡ธ USA